Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
At the Colon and Rectal Cancer Center, our mission is to deliver compassionate, multi-disciplinary, leading-edge colon and rectal cancer care, providing patients and their families with access to a comprehensive range of services based on specialized treatment modalities and innovative research.
We created the Colon and Rectal Cancer Center to give each patient the best outcome possible. Our Center's highly specialized clinical team brings together experts from two world-class medical centers — Dana-Farber Cancer Institute and Brigham and Women's Hospita l— who are changing the way colon and rectal cancer is studied, diagnosed, and treated. This approach includes genetic screening, family
risk assessment, specialized endoscopic treatments, minimally invasive and robotic surgery, targeted therapies, clinical trials, and recurrence prevention.
We have expertise treating patients at all stages of colon and rectal cancer, including those with straightforward diagnoses, as well as those with complex conditions who need cross-disciplinary expertise. Each of our patients receives the most comprehensive care possible. We work closely as a team to consider any and all options and create a customized treatment plan for every patient.
Our medical, surgical, and radiation oncologists, endoscopy specialists, gastroenterologists, radiologists, and pathologists work every day to improve outcomes for patients with colon or rectal cancer, as they research new ways to prevent, diagnose, and treat these diseases. We offer an approach to treatment that includes:
Learn about how we
diagnose and treat colon cancer.
Learn about how we
diagnose and treat rectal cancer.
Appointments and Second Opinions
Dana-Farber’s Nadine J. McCleary, MD, MPH, discusses the latest in research and treatment for colorectal cancers in a Facebook Live Q&A.